Sensitivity Pattern Of Salmonella typhi And Paratyphi A Isolates To Chloramphenicol And Other Anti-Typhoid Drugs: An In Vitro Study

References

• Kanungo S, Dutta S, Sur D. Epidemiology of typhoid and paratyphoid fever in India. J Infect Dev Ctries. 2008;2(6):454–460.19745523
   PubMed Web of Science ®Google Scholar
• Mogasale V, Maskery B, Ochiai RL, et al. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health. 2014;2(10):e570–e580. doi:10.1016/S2214-109X(14)70301-825304633
   PubMed Web of Science ®Google Scholar
• Nagashetty K, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries. 2010;4(2):70–73.20212336
   PubMed Web of Science ®Google Scholar
• Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86(4):260–268. doi:10.2471/blt.06.03981818438514
   PubMed Web of Science ®Google Scholar
• Dutta S, Das S, Mitra U, et al. Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica serovars Typhi and Paratyphi A blood isolates from Kolkata, India during 2009‑2013. PLoS One. 2014;9(8):e101347. doi:10.1371/journal.pone.010134725098613
   PubMed Web of Science ®Google Scholar
• Jesudason MV, John TJ. Plasmid mediated multidrug resistance in Salmonella Typhi. Indian J Med Res. 1992;95:66–67.1601471
   PubMed Web of Science ®Google Scholar
• Mohanty S, Renucca K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of salmonella serotypes in a north Indian tertiary care hospital. Epidemiol Infect. 2006;134(5):961–966. doi:10.1017/S095026880500584416476168
   PubMed Web of Science ®Google Scholar
• Bhatia JK, Mathur AD, Arora MM. Re-emergence of chloramphenicol sensitivity in enteric fever. Med J Armed Forces India. 2007;63(3):212–214. doi:10.1016/S0377-1237(07)80136-527407999
   PubMedGoogle Scholar
• Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med Hyg. 2004;98(7):423–430. doi:10.1016/j.trstmh.2003.10.01515138079
   PubMed Web of Science ®Google Scholar
• Mandal S, Mandal MD, Kumar PN. Reduced minimum inhibitory concentration of chloramphenicol for salmonella enterica serovar typhi. Ind J Med Sci. 2004;58(1):16–23.
   PubMedGoogle Scholar
• Sheorey HS, Kaundinya DV, Hulyalkar VS, Deshpande AK. Multidrug resistant Salmonella Typhi in Bombay. Indian J Patho Microbiol. 1993;36(1):8–12.
   Google Scholar
• Mishra S, Patwari AK, Anand VK, et al. A clinical profile of multidrug resistant typhoid fever. Indian Pediatr. 1991;28(10):1171–1174.1797669
   PubMedGoogle Scholar
• Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai–clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India. 2008;56:237–240.18702385
   PubMedGoogle Scholar
• Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. Afr J Microbiol Res. 2010;4(3):197–203.
   Google Scholar
• Halder KK, Dalal BS, Ghose E, Sanyal S. Chloramphenicol resistant Salmonella typhi: the cause of recent out-break of enteric fever in Calcutta. Indian J Pathol Microbiol. 1992;35(1):11–17.1452239
   PubMedGoogle Scholar
• Rathish KC, Chandrashekar MR, Nagesha CN. An outbreak of multidrug resistant typhoid fever in Bangalore. Ind J Pediatr. 1995;62(4):445–448. doi:10.1007/BF2755065
   Google Scholar
• Ciraj AM, Seetha KS, Gopalakrishna BK, Shivananda PG. Drug resistance pattern and Phage types of Salmonella typhi isolates in Manipal, South Karnataka. Ind J Med Sci. 1999;53(11):486–489.
   Google Scholar
• Butler T, Linh NN, Arnold K, Pollack M. Chloramphenicol resistant typhoid fever in Vietnam associated with R factor. Lancet. 1973;302(7836):983–985. doi:10.1016/s0140-6736(73)91086-64127275
   PubMed Web of Science ®Google Scholar
• Brown JD, Duong Hong M, Rhoades ER. Chloramphenicol resistant Salmonella Typhi in Saigon. JAMA. 1975;231(2):162–166.1172682
   PubMed Web of Science ®Google Scholar
• Chun D, Seol SY, Cho DT, Tak R. Drug resistance and R plasmids in Salmonella Typhi isolated in Korea. Antimicrob Agents Chemother. 1977;11(2):209–213. doi:10.1128/aac.11.2.209848922
   PubMed Web of Science ®Google Scholar
• Rowe B, Ward LR, Threlfall EJ. Multidrug-resistant Salmonella Typhi: a worldwide epidemic. Clin Infect Dis. 1997;24(Suppl 1):S106–S109. doi:10.1093/clinids/24.supplement_1.s1068994789
   PubMed Web of Science ®Google Scholar
• Zaki SA, Karande S. Multidrug-resistant typhoid fever: a review. J Infect Dev Ctries. 2011;5(5):324–337.21628808
   PubMed Web of Science ®Google Scholar
• Tankhiwale SS, Agrawal G, Jalgaonkar SV. A preliminary report on current antibiogram of salmonella enterica serotype typhi in Nagpur. Indian J Med Microbiol. 2003;21(4):292.17643050
   PubMedGoogle Scholar
• Sood S, Kapil A, Das B, et al. Re-emergence of chloramphenicol-sensitive Salmonella typhi. Lancet. 1999;353(9160):1241–1242. doi:10.1016/s0140-6736(99)00637-6
   PubMed Web of Science ®Google Scholar
• Gupta V, Kaur J, Kaistha N. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype Typhi isolates in North India. Trop Doct. 2009;39(1):28–30. doi:10.1258/td.2008.07045219211419
   PubMed Web of Science ®Google Scholar
• Karkey A, Thwaites GE, Baker S. The evolution of antimicrobial resistance in Salmonella Typhi. Curr Opin Gastroenterol. 2018;34(1):25–30. doi:10.1097/MOG.000000000000040629059070
   PubMed Web of Science ®Google Scholar
• Choudhary A, Gopalakrishnan R, Nambi PS, Ramasubramanian V, Ghafur KA, Thirunarayan MA. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India. Indian J Med Res. 2013;137(4):800–802.23703350
   PubMed Web of Science ®Google Scholar
• Monica KH, Devi K, Devi S, Banylla S. Antibiogram of Salmonella typhi isolated from Enteric fever cases in a tertiary health care Centre in Imphal. Int J Pharmacol Ther. 2014;4:15–18.
   Google Scholar
• Nachnani S, Scuteri A, Newman MG, Avanessian AB, Lomeli SL. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms. J Periodontol. 1992;63(7):576–583. doi:10.1902/jop.1992.63.7.5761324301
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 28th CLSI supplement M100 Wayne, PA: Clinical and Laboratory Standards Institute; 2018
   Google Scholar
• Jorgensen J, Ferraro MJ. Antibiotic susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis. 2009;49(11):1749–1755. doi:10.1086/64795219857164
   PubMed Web of Science ®Google Scholar
• Mahon C, Lehman D, Manuselis G. Textbook of Diagnostic Microbiology. 4 ed. Maryland Heights: Saunders Elsevier; 2011.
   Google Scholar
• Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enterica serovar Typhi and Paratyphi A from blood samples of suspected enteric fever patients. Int J Infect Microbial. 2012;1(1):9‐13.
   Google Scholar
• Ramesh U, Das S, Balasubramanian A. Re-emergence of chloramphenicol-susceptible Salmonella Typhi and Paratyphi A strains in India. Indian J Med Microbiol. 2016;34(2):262–263. doi:10.4103/0255-0857.18039327080799
   PubMed Web of Science ®Google Scholar
• Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram Salmonella typhi & S. paratyphi A isolated from Rourkela, Orissa. Ind J Med Microbiol. 2011;133:431–433.
   Google Scholar
• World Health Organization. Indian network for surveillance of antimicrobial resistance. antibiogram of Salmonella enterica serovar typhi and Salmonella enterica serovar paratyphi A: a multi-centre study from India. WHO South-East Asia J Public Health. 2012;1:182–188. doi:10.4103/2224-3151.20693028612793
   PubMedGoogle Scholar
• Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar typhi and paratyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis. 2006;54(4):299–303. doi:10.1016/j.diagmicrobio.2005.10.01616466897
   PubMed Web of Science ®Google Scholar
• Pramod P, Binod L, Ritu A, Sharad B, Prakash P. Enteric fever caused by Salmonella enterica serovar paratyphi A: an emerging health concern in Nepal. Afr J Microbiol Res. 2016;10(42):1784–1791. doi:10.5897/AJMR
   Google Scholar
• Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol. 2010;28(1):51–53. doi:10.4103/0255-0857.5873020061765
   PubMed Web of Science ®Google Scholar
• Wu W, Wang H, Lu J, Wu J. Genetic diversity of Salmonella typhi and paratyphi in Shenzhen, China from 2002 to 2007. BMC Microbiol. 2010;10:32–38. doi:10.1186/1471-2180-10-3220113512
   PubMed Web of Science ®Google Scholar
• Acharya D, Bhatta DR, Malla S, Dumre SP, Adhikari N, Kandel BP. Salmonella enterica serovar Paratyphi A: an emerging cause of febrile illness in Nepal. Nepal Med Coll J. 2011;13(2):69–73.22364084
   PubMedGoogle Scholar
• Sood S, Kapil A, Dash N, et al. Paratyphoid fever in India: an emerging problem. Emerg Infect Dis. 1999;5(3):483–484. doi:10.3201/eid0503.99032910341194
   PubMed Web of Science ®Google Scholar
• Bhattacharya SS, Das U. Occurrence of Salmonella typhi infection in Rourkela, Orissa. Indian J Med Res. 2000;111:75–76.10937381
   PubMed Web of Science ®Google Scholar
• Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types and drug resistance of Salmonella typhi in Ludhiana during 1980-1999. Ind J Med Res. 2001;113:175–180.
   Web of Science ®Google Scholar
• Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis. 2002;6(6):281–287. doi:10.1590/S1413-8670200200060000312585971
   PubMedGoogle Scholar
• Rodrigues C, Mehta A, Joshi VR. Salmonella typhi in the past decade: learning to leave with resistance. Clin Infect Dis. 2002;34(1):126. doi:10.1086/32301911731956
   PubMed Web of Science ®Google Scholar
• Chande C, Shrikhande S, Kapali S, Agarwal S, Fule RP. Change in antimicrobial pattern of Salmonella Typhi in central India. Indian J Med Res. 2002;115:248–250.12440196
   PubMed Web of Science ®Google Scholar
• Mirza SH, Beeching NJ, Hart CA. Multi-drug resistant typhoid: a global problem. J Med Microbiol. 1996;44(5):317–319. doi:10.1099/00222615-44-5-3178636944
   PubMed Web of Science ®Google Scholar
• Yashavanth R, Vidyalakshmi K. The re-emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res. 2010;4(5):3106–3108.
   Google Scholar
• Sania KM, Shyamasakhi PD, Pramodini KD, Sulochana KD. Evaluation of minimum inhibitory concentration of chloramphenicol for salmonella spp. Isolated from enteric fever cases in a tertiary hospital in Imphal. Int J Pharm Sci Res. 2016;7(9):3815–3819.
   Google Scholar
• Chang HR, Vladoianu IR, Pechèe JC. Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella Typhi within human monocyte-derived macrophages. J Antimicrob Chemother. 1990;26(5):689–694. doi:10.1093/jac/26.5.6892079450
   PubMed Web of Science ®Google Scholar
• Ekinci B, Coban AY, Birinci A, Durupinar B, Erturk M. In vitro effects of cefotaxime and ceftriaxone on Salmonella Typhi within human monocyte-derived macrophages. Clin Microbiol Infect. 2002;8(12):810–813.12519356
   PubMed Web of Science ®Google Scholar
• Cao XT, Kneen R, Nguyen TA, Truong DL, White NJ, Parry CM. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J. 1999;18(3):245–248. doi:10.1097/00006454-199903000-0000710093945
   PubMed Web of Science ®Google Scholar
• Panteix G, Guillaumond B, Harf R, et al. In vitro concentration of azithromycin in human phagocytic cells. J Antimicrob Chemother. 1993;31(SupplE):1–4. doi:10.1093/jac/31.suppl_e.1
   Google Scholar
• Rakita RM, Jacques-Palaz K, Murray BE. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother. 1994;38(9):1915–1921. doi:10.1128/aac.38.9.19157810998
   PubMed Web of Science ®Google Scholar
• Gladue RP, Bright GM, Isaacson RE, Newborg MF. In-vitro and in-vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanisms of delivery and release at sites of infection. Antimicrob Agents Chemother. 1989;33(3):277–282. doi:10.1128/aac.33.3.2772543276
   PubMed Web of Science ®Google Scholar
• Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet. 2005;366(9487):749–762. doi:10.1016/S0140-6736(05)67181-416125594
   PubMed Web of Science ®Google Scholar
• Bhetwal A, Maharjan A, Khanal PR, et al. Enteric fever caused by salmonella enterica serovars with reduced susceptibility of Fluoroquinolones at a community based teaching hospital of Nepal. Int J Microbiol. 2017;2017:2869458. doi:10.1155/2017/286945829234353
   PubMed Web of Science ®Google Scholar
• Chayani N, Tiwari S, Sarangi G, et al. Role of azithromycin against clinical isolates of family enterobacteriaceae: a comparison of its minimum inhibitory concentration by three different methods. Indian J Med Microbiol. 2009;27(2):107–110. doi:10.4103/0255-0857.4536119384031
   PubMed Web of Science ®Google Scholar
• Butler T, Sridhar CB, Daga MK, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicenter trial in India. J Antimicrob Chemother. 1999;44:243–250. doi:10.1093/jac/44.2.24310473232
   PubMed Web of Science ®Google Scholar
• Frenck RW, Nakhla IA, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis. 2000;31:1134–1138. doi:10.1086/31745011073741
   PubMed Web of Science ®Google Scholar
• Frenck RW, Mansour A, Nakhla I, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis. 2004;38:951–957. doi:10.1086/38235915034826
   PubMed Web of Science ®Google Scholar
• Chinh NT, Parry CM, Ly NT, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother. 2000;44:1855–1859. doi:10.1128/aac.44.4.1029-1034.200010858343
   PubMed Web of Science ®Google Scholar
• Parry CM, Ho VA, Phuong LT, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007;46:819–825. doi:10.1128/AAC.00447-06
   Web of Science ®Google Scholar
• Dolecek C, Tran TP, Nguyen NR, et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One. 2008;3:e2188. doi:10.1371/journal.pone.000218818493312
   PubMed Web of Science ®Google Scholar
• Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2011;10:CD006083.
   Google Scholar
• Crump JA, Sj¨olund-Karlsson M, Gordon MA, Parry CM. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin Microbiol Rev. 2015;28(4):901–937. doi:10.1128/CMR.00064-1526180063
   PubMed Web of Science ®Google Scholar
• Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33(3):C21–C29. doi:10.1016/j.vaccine.2015.03.10225912288
   PubMed Web of Science ®Google Scholar
• Rai S, Jain S, Prasad KN, Ghoshal U, Dhole TN. Rationale of azithromycin prescribing practices for enteric fever in India. Indian J Med Microbiol. 2012;30(1):30–33. doi:10.4103/0255-0857.9301722361757
   PubMed Web of Science ®Google Scholar
• Patel SR, Bharti S, Pratap CB, Nath G. Drug resistance pattern in the recent isolates of Salmonella typhi with special reference to cephalosporins and azithromycin in the gangetic plain. J Clin Diagn Res. 2017;11(6):DM01–DM03.
   Web of Science ®Google Scholar
• Gonza´ Lez-Lo´ Pez JJ, Piedra-Carrasco N, Salvador F, et al. ESBL-producing Salmonella enterica Serovar typhi in traveler returning from Guatemala to Spain. Emerg Infect Dis. 2014;20(11):1918–1920. doi:10.3201/eid2011.14052525340972
   PubMed Web of Science ®Google Scholar
• Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum b-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect. 2014;20(2):O109–O116. doi:10.1111/1469-0691.1233923992040
   PubMed Web of Science ®Google Scholar
• Ahmed D, Hoque A, Mazumder R, et al. Salmonella enterica serovar typhi strain producing extended-spectrum -lactamases in Dhaka, Bangladesh. J Med Microbiol. 2012;61(Pt 7):1032–1033. doi:10.1099/jmm.0.044065-022442289
   PubMed Web of Science ®Google Scholar
• Braoudaki M, Hilton AC. Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. Int J Antimicrob Agents. 2005;25:31–37. doi:10.1016/j.ijantimicag.2004.08.02015620823
   PubMed Web of Science ®Google Scholar
• Acharya GP, Davis TM, Ho M, et al. Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever. J Antimicrob Chemother. 1997;40(1):91–98. doi:10.1093/jac/40.1.919249209
   PubMed Web of Science ®Google Scholar